类风湿关节炎的中医药研究进展  

Research Progress of TCM Treating RA

作　　者：贾文瑞 赵永星[1] JIA Wenrui;ZHAO Yongxing(Zhengzhou University, Zhengzhou 450001, China;The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China)

机构地区：[1]郑州大学,河南郑州450001 [2]郑州大学第一附属医院,河南郑州450052

出　　处：《中医药信息》2019年第1期117-120,共4页Information on Traditional Chinese Medicine

摘　　要：类风湿关节炎是临床常见自身免疫性疾病之一,可以对人体造成永久性伤害。目前,我国类风湿关节炎(RA)的患病率呈现逐年升高趋势。通过检索、分析文献,发现无论中药复方、中成药、单味中药、中药提取物、针灸、外治以及中医药联用等多种治疗方式,在治疗RA方面多优于单用常规化学药物,不仅可以显著改善RF、ESR水平、患者晨僵时间,延缓病情进展,减少肝肾损害,且一些药物(如白芍总苷)还能降低常规化学药物的肝损伤等副作用,充分证明中医药在疗效和安全性上具有显著优势,值得临床推广应用。Rheumatoid arthritis(RA) is one of the common clinical autoimmune diseases, which causes permanent damage to human body. At present, the prevalence rate of RA shows an increasing trend year by year. This study found that TCM therapy, no matter it was TCM compound formula, Chinese patent medicine, single Chinese medicinal, Chinese herb extracts, acupuncture and moxibustion, TCM external treatment, or TCM combination therapy, they were all superior to the single routine chemicals in the treatment of RA. TCM therapy can significantly improve the levels of RF and ESR, shorten the morning stiffness time, delay RA progression, and reduce liver damage. Some Chinese medicinal, such as total glucosides of paeony, can also reduce the liver damage caused by chemicals, which fully proved TCM has advantages in efficacy and safety when treating RA.

关 键 词：类风湿关节炎 中医药 综述 

分 类 号：R259[医药卫生—中西医结合] R593.22[医药卫生—中医内科学]